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TO THE EDITOR, 
 
Ectodermal dysplasia (ED) comprises a large, heterogeneous group of inherited disorders 
defined by developmental defects in two or more tissues derived from embryonic ectoderm, 
including the skin, its appendages (i.e., hair follicles, eccrine glands, sebaceous glands, and 
nails) and teeth (Itin, 2014). The marked heterogeneity of ED hinders accurate genotype-
phenotype correlation, although application of next generation sequencing has added 
further insights (Lin et al., 2012; Petrof et al., 2014; Raykova et al., 2014). Clinical 
assessment and accurate diagnosis are further compounded by observations that congenital 
nail or hair disorders may occur as isolated phenomena (Khan et al., 2015; Shimomura, 
2012). Here, we investigate a case presenting with congenital anonychia and uncombable 
sparse hair, and use whole exome sequencing (WES) to demonstrate that the phenotype 
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results from two separate autosomal recessive disorders rather than a single variant of ED. 
Permission from the subject’s guardian (and also the guardians of the other children 
mentioned in this report) was given for publication of clinical images and data. 
The proband, a 4-year-old Kuwaiti boy born to consanguineous parents, had 
complete absence of all 20 nails from birth (Figure 1a). In addition, he had somewhat sparse 
scalp hair that was slow to grow, of wavy texture, and difficult to comb (Figure 1b). There 
was no other abnormality apart from a congenital squint. The proband is shown as 
individual IV-3 in the pedigree (Figure 1c). Clinical abnormalities were also present in his 
cousins (individuals IV-5, IV-6, and IV-7 in Figure 1c), again born to consanguineous parents. 
Those siblings had a similar absence of all 20 nails but lacked any hair abnormalities (Figure 
1d). The clinical conundrum was whether the proband with anonychia and hair 
abnormalities had a different ED disorder or whether he might have two separate 
autosomal recessive ectodermal conditions. With regard to the anonychia, biallelic 
mutations in RSPO4 (OMIM 610573) have been identified in autosomal recessive congenital 
anonychia/hyponychia (Bergmann et al., 2006; Blaydon et al., 2006).  The encoded protein, 
R-spondin 4, is expressed in nail mesenchyme and acts as an activator of Wnt/β-catenin 
signaling, notably for nails (Blaydon et al., 2006). Following written informed consent and 
institutional ethics approval, we Sanger-sequenced RSPO4, using published methods 
(Blaydon et al., 2006), and identified a homozygous donor splice-site mutation, IVS1+1G>A, 
in all anonychic individuals, including the proband and his three cousins (Figure 2a). To date, 
18 mutations in RSPO4 have been identified in isolated congenital anonychia/hyponychia 
(Khan et al., 2015). The particular splice-site mutation in our pedigree previously has been 
reported as pathogenic (Blaydon et al., 2006).  
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To delineate the genetic basis of the hair abnormality, WES was performed on the 
Illumina NextSeq 500 platform using genomic DNA samples from the proband and both his 
unaffected parents (trio). Using various in silico pathogenicity prediction tools, including SIFT, 
PolyPhen-2, MutationTaster, CADD and DANN, and models of autosomal recessive or de 
novo dominant inheritance, we identified 11 possible autosomal recessive mutations and 3 
de novo dominant changes (Tables S1 and S2).  A nonsynonymous homozygous mutation in 
PADI3 (peptidyl arginine deiminase, type III) (c.1372C>A; p.Pro458Thr) was thought to be 
the most likely causative finding (SIFT: 0; Polyphen-2: 0.989; MutationTaster: 0.997; CADD: 
26.3; DANN: 0.998). This mutation is very rare in the general population (25 heterozygous 
allele counts among 121406 alleles in the ExAC Browser, http://exac.broadinstitute.org/) 
with no homozygotes. Sanger sequencing confirmed this homozygous missense mutation in 
PADI3 in the proband’s DNA. Only the proband was homozygous; the other unaffected 
family members were wild-type (WT) or heterozygous carriers (Figure 2b, c). 
Peptidylarginine deiminases (protein name abbreviated to PAD; gene name 
abbreviated to PADI) are Ca
2+
-dependent enzymes responsible for the formation of protein-
bound citrulline, first detected in the hair follicles (HF) of the guinea-pig (Rogers and Taylor, 
1977). In humans, five different isoforms (PAD1–4 and PAD6) have been identified in various 
tissues and all are clustered on 1p35–36 (Vossenaar et al., 2003). PAD-3 is involved in 
deiminating trichohyalin in the HF medulla and Henle layer (Nachat et al., 2005). The 
relevance of PAD-3 to hair biology has been further emphasized by the recent discovery of 
biallelic PADI3 mutations in 9 cases/families with uncombable hair syndrome (Basmanav et 
al., in press). The mutations reported comprise three missense variants: c.335T>A 
(p.Leu112His), c.881C>T (p.Ala294Val), and c.1813C>A (p.Pro605Thr) (Figure 2d), either as 
homozygous or compound heterozygous findings (Basmanav et al., in press). Our 
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homozygous amino acid substitution, p.Pro458Thr, occurs in the PAD domain, which is 
important for protein-arginine deiminase activity and calcium ion binding.  
To examine the functional significance of p.Pro458Thr, we engineered a mutant 
construct by performing site-specific mutagenesis on the vector that was previously used to 
study the other PADI3 mutations (see Basmanav et al., in press, for full details). The 
construct contains the WT PADI3 sequence (1995 bp) inserted into the pcDNA3.1 V5/His 
TOPO TA vector (Invitrogen). Mutagenesis was performed using the QuikChange II Site-
Directed Mutagenesis kit according to the manufacturer’s instructions (Agilent 
Technologies) with verification by Sanger sequencing. Western blotting of extracts from 
HaCaT cells transfected with the WT and mutant PADI3 constructs showed a 4.7-fold 
reduction in PADI3 mutant protein (Figure 2e). Immunofluorescence microscopy of HaCaT 
cells revealed stark differences in the distribution of WT and mutant proteins. While WT 
PADI3 was homogeneously distributed in the cytosol, the mutant protein formed aggregates, 
which were diffuse in the cytoplasm and particularly evident around the nucleus (Figure 2f). 
These results were similar to the cell pathology shown for the reported p.Ala294Val and 
p.Pro605Thr constructs, although our mutant construct (p.Pro458Thr) was associated with 
more aggregation than was seen for the previously assessed mutant p.Leu112His (Basmanav 
et al., in press). In contrast, no aggregates at all were observed in cells transfected with WT 
constructs. 
The hair phenotype in our proband was also uncombable, due to its wavy textural 
change, but was predominantly sparse and slow growing, thus differing slightly from all but 
one of the other reported PADI3 cases (Basmanav et al., in press) and underscoring the 
range of hair pathologies that can result from PADI3 mutations. Our case also highlights the 
value of WES in identifying co-inheritance of two distinct autosomal recessive conditions in 
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consanguineous pedigrees which, for one individual herein, jointly gave rise to an 
ectodermal dysplasia phenotype. 
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Figure legends 
 
Figure 1. Nail and hair abnormalities in the proband and extended pedigree. (a) Complete 
absence of all 20 nails in the proband; (b) The proband has somewhat sparse wavy scalp hair 
that is slow to grow and difficult to comb; (c) The proband (IV-3, arrow) is the third child of 
consanguineous parents with one unaffected sister and one unaffected brother. Three 
cousins (IV-5, IV-6 and IV-7) also have anonychia but no hair abnormalities. (d) The cousins 
of the proband (IV-5, IV-6 and IV-7) manifest anonychia without hair abnormalities. 
 
Figure 2. Co-inheritance of two separate autosomal recessive disorders accounts for the 
ectodermal dysplasia phenotype (a) Sanger sequencing identifies a recurrent homozygous 
donor splice-site mutation in RSPO4 (IVS1+1G>A) in all subjects with anonychia, including 
the proband and three cousins; (b) Sanger sequencing confirms the proband’s homozygous 
missense mutation in PADI3 (c.1372C>A; p.Pro458Thr), originally identified by WES trio 
analysis. The proband is homozygous for the PADI3 mutation, while other unaffected family 
members are wild-type or heterozygous carriers; (c) Verification of the mutation by 
HpyCH4III restriction enzyme digestion (New England BioLabs). The mutation c.1372C>A 
creates a new cut site such that the 452-bp band is cleaved into 300-bp and 152-bp products. 
For the patient (IV-3) two cleaved bands are present, whereas in carriers (III-3, III-4, and III-8) 
three discrete bands are seen. For the wild type only the single undigested upper band is 
visible. NC, negative control; PC, positive control; MW, molecular weight ladder. (d) 
Schematic illustration of the PAD-3 protein and the mutations identified thus far (new 
mutation boxed in red); (e) Immunoblot analysis of protein extracts from transiently 
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transfected HaCaT cells shows a reduced expression of mutant PADI3 protein level 
compared to wild-type (wt); immunoblotting was performed with anti-V5 antibody. (f) 
Immunofluorescence analysis in HaCaT cells transiently expressing WT and mutant PADI3 
shows the homogeneous cytosolic expression of WT PADI3 whereas the mutant protein is 
observed in the form of large aggregates (scale bar = 10 µm).  
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